Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid Drug Desensitization With Rituximab in 24 Cases: A Single-Center Experience.
Görgülü B, Seval GC, Kendirlinan R, Toprak SK, Özcan M, Bavbek S. Görgülü B, et al. Among authors: seval gc. J Investig Allergol Clin Immunol. 2019;29(6):468-470. doi: 10.18176/jiaci.0445. Epub 2019 Sep 18. J Investig Allergol Clin Immunol. 2019. PMID: 31530515 Free article. No abstract available.
Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia.
Ozdemir ZN, Kircali E, Şahin U, Seval GC, Bozdağ SC, Toprak SK, Yuksel MK, Topcuoglu P, Arslan O, Demirer T, Ilhan O, Beksac M, Gurman G, Ozcan M. Ozdemir ZN, et al. Among authors: seval gc. Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):596-600. doi: 10.1016/j.clml.2022.02.007. Epub 2022 Mar 12. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35410758
Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease.
Koyun D, Seval GC, Kırcalı E, Bozdağ SC, Toprak SK, Topçuoğlu P, Özcan M, Arslan Ö, Demirer T, İlhan O, Beksaç M, Gürman G, Yüksel MK. Koyun D, et al. Among authors: seval gc. Indian J Hematol Blood Transfus. 2022 Jul;38(3):601-605. doi: 10.1007/s12288-022-01524-2. Epub 2022 Feb 7. Indian J Hematol Blood Transfus. 2022. PMID: 35747565 Free PMC article.
Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Single-center Experience on Efficacy, Safety and Survival Outcome.
Beksac M, Seval GC, Koyun D, Topcuoglu P, Yuksel MK, Gurman G, Ilhan O. Beksac M, et al. Among authors: seval gc. Clin Lymphoma Myeloma Leuk. 2023 Mar;23(3):e164-e170. doi: 10.1016/j.clml.2022.12.007. Epub 2022 Dec 9. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36610852 Free article.
Xanthelasma palpebrarum: a new side effect of nilotinib.
Sayin I, Ayli M, Oğuz AK, Seval GC. Sayin I, et al. Among authors: seval gc. BMJ Case Rep. 2016 Jan 12;2016:bcr2015213511. doi: 10.1136/bcr-2015-213511. BMJ Case Rep. 2016. PMID: 26759444 Free PMC article.
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome.
Beksac M, Seval GC, Kanellias N, Coriu D, Rosiñol L, Ozet G, Goranova-Marinova V, Unal A, Bila J, Ozsan H, Ivanaj A, Balić LI, Kastritis E, Bladé J, Dimopoulos MA. Beksac M, et al. Among authors: seval gc. Haematologica. 2020 Jan;105(1):201-208. doi: 10.3324/haematol.2019.219295. Epub 2019 Jul 5. Haematologica. 2020. PMID: 31278209 Free PMC article.
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L, Salmanton-García J, Marchesi F, Busca A, Corradini P, Hoenigl M, Klimko N, Koehler P, Pagliuca A, Passamonti F, Verga L, Víšek B, Ilhan O, Nadali G, Weinbergerová B, Córdoba-Mascuñano R, Marchetti M, Collins GP, Farina F, Cattaneo C, Cabirta A, Gomes-Silva M, Itri F, van Doesum J, Ledoux MP, Čerňan M, Jakšić O, Duarte RF, Magliano G, Omrani AS, Fracchiolla NS, Kulasekararaj A, Valković T, Poulsen CB, Machado M, Glenthøj A, Stoma I, Ráčil Z, Piukovics K, Navrátil M, Emarah Z, Sili U, Maertens J, Blennow O, Bergantim R, García-Vidal C, Prezioso L, Guidetti A, Del Principe MI, Popova M, de Jonge N, Ormazabal-Vélez I, Fernández N, Falces-Romero I, Cuccaro A, Meers S, Buquicchio C, Antić D, Al-Khabori M, García-Sanz R, Biernat MM, Tisi MC, Sal E, Rahimli L, Čolović N, Schönlein M, Calbacho M, Tascini C, Miranda-Castillo C, Khanna N, Méndez GA, Petzer V, Novák J, Besson C, Duléry R, Lamure S, Nucci M, Zambrotta G, Žák P, Seval GC, Bonuomo V, Mayer J, López-García A, Sacchi MV, Booth S, Ciceri F, Oberti M, Salvini M, Izuzquiza M, Nunes-Rodrigues R, Ammatuna E, Obr A, Herbrecht R, Núñez-Martín-Buitrago L, Mancini V, Shwaylia H, Sciumè M, Essame J, Nygaard M, Batinić J, Go… See abstract for full author list ➔ Pagano L, et al. Among authors: seval gc. J Hematol Oncol. 2021 Oct 14;14(1):168. doi: 10.1186/s13045-021-01177-0. J Hematol Oncol. 2021. PMID: 34649563 Free PMC article. Clinical Trial.
28 results